Laura V. Ashton

724 total citations
26 papers, 508 citations indexed

About

Laura V. Ashton is a scholar working on Epidemiology, Molecular Biology and Parasitology. According to data from OpenAlex, Laura V. Ashton has authored 26 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Molecular Biology and 7 papers in Parasitology. Recurrent topics in Laura V. Ashton's work include Herpesvirus Infections and Treatments (7 papers), Vector-borne infectious diseases (6 papers) and Listeria monocytogenes in Food Safety (5 papers). Laura V. Ashton is often cited by papers focused on Herpesvirus Infections and Treatments (7 papers), Vector-borne infectious diseases (6 papers) and Listeria monocytogenes in Food Safety (5 papers). Laura V. Ashton collaborates with scholars based in United States and Germany. Laura V. Ashton's co-authors include Claudia R. Molins, Martin E. Schriefer, Mark J. Delorey, Gisela Soboll Hussey, Lutz S. Goehring, D.P. Lunn, John T. Belisle, Gary P. Wormser, John N. Sofos and Ann M. Hess and has published in prestigious journals such as Applied and Environmental Microbiology, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Laura V. Ashton

26 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura V. Ashton United States 15 229 204 138 130 82 26 508
Hema P. Narra United States 14 212 0.9× 163 0.8× 100 0.7× 113 0.9× 183 2.2× 29 574
V. Jiménez-Lucho United States 11 209 0.9× 301 1.5× 146 1.1× 144 1.1× 85 1.0× 16 633
N Teysseire France 9 314 1.4× 181 0.9× 53 0.4× 154 1.2× 83 1.0× 10 509
Christine J. Hastey United States 10 244 1.1× 298 1.5× 60 0.4× 74 0.6× 52 0.6× 16 528
Kiyotaka Yoshiie Japan 12 277 1.2× 167 0.8× 47 0.3× 97 0.7× 74 0.9× 21 475
Kyaw Min Aung Sweden 13 99 0.4× 140 0.7× 63 0.5× 55 0.4× 281 3.4× 21 600
Robert G. Schaut United States 14 48 0.2× 103 0.5× 113 0.8× 166 1.3× 57 0.7× 27 407
Punsiri M. Colonne United States 8 78 0.3× 220 1.1× 87 0.6× 97 0.7× 166 2.0× 9 618
C. Mary France 14 262 1.1× 169 0.8× 404 2.9× 537 4.1× 32 0.4× 26 824
S Devi Malaysia 12 112 0.5× 274 1.3× 53 0.4× 220 1.7× 45 0.5× 28 512

Countries citing papers authored by Laura V. Ashton

Since Specialization
Citations

This map shows the geographic impact of Laura V. Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura V. Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura V. Ashton more than expected).

Fields of papers citing papers by Laura V. Ashton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura V. Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura V. Ashton. The network helps show where Laura V. Ashton may publish in the future.

Co-authorship network of co-authors of Laura V. Ashton

This figure shows the co-authorship network connecting the top 25 collaborators of Laura V. Ashton. A scholar is included among the top collaborators of Laura V. Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura V. Ashton. Laura V. Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashton, Laura V., Kristen Weishaar, Bernard Séguin, & Amy L. MacNeill. (2023). Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma. Biomedicines. 11(9). 2346–2346. 1 indexed citations
4.
Miller, Matthew L., et al.. (2021). Light chain myeloma and detection of free light chains in serum and urine of dogs and cats. Journal of Veterinary Internal Medicine. 35(2). 1031–1040. 11 indexed citations
6.
Burgess, Brandy A., et al.. (2020). Environmental persistence of equid herpesvirus type‐1. Equine Veterinary Journal. 53(2). 349–355. 17 indexed citations
7.
Ashton, Laura V., Barbara Graham, Maryam F. Afzali, Daniel L. Gustafson, & Amy L. MacNeill. (2020). <p>Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib</p>. PubMed. Volume 9. 17–29. 1 indexed citations
8.
Graham, Barbara, Kristofor J. Webb, Laura V. Ashton, et al.. (2019). A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome. International Journal of Infectious Diseases. 84. 30–38. 20 indexed citations
9.
Molins, Claudia R., M. Nurul Islam, Barbara Graham, et al.. (2019). Host Metabolic Response in Early Lyme Disease. Journal of Proteome Research. 19(2). 610–623. 18 indexed citations
10.
Pegalajar‐Jurado, Adoracion, M. Nurul Islam, John T. Belisle, et al.. (2018). Identification of Urine Metabolites as Biomarkers of Early Lyme Disease. Scientific Reports. 8(1). 12204–12204. 15 indexed citations
11.
Molins, Claudia R., Laura V. Ashton, Gary P. Wormser, et al.. (2015). Development of a Metabolic Biosignature for Detection of Early Lyme Disease. Clinical Infectious Diseases. 60(12). 1767–1775. 61 indexed citations
12.
Hussey, Gisela Soboll, et al.. (2014). Equine herpesvirus type 1 pUL56 modulates innate responses of airway epithelial cells. Virology. 464-465. 76–86. 24 indexed citations
13.
Hussey, Gisela Soboll, et al.. (2014). Innate immune responses of airway epithelial cells to infection with Equine herpesvirus-1. Veterinary Microbiology. 170(1-2). 28–38. 27 indexed citations
14.
Goehring, Lutz S., Gisela Soboll Hussey, Laura V. Ashton, Alan R. Schenkel, & D.P. Lunn. (2010). Infection of central nervous system endothelial cells by cell-associated EHV-1. Veterinary Microbiology. 148(2-4). 389–395. 21 indexed citations
15.
Hussey, Gisela Soboll, D.P. Lunn, Laura V. Ashton, et al.. (2010). Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia. Veterinary Microbiology. 149(1-2). 40–47. 26 indexed citations
16.
Skandamis, P.N., J.D. Stopforth, Laura V. Ashton, et al.. (2008). Escherichia coli O157:H7 survival, biofilm formation and acid tolerance under simulated slaughter plant moist and dry conditions. Food Microbiology. 26(1). 112–119. 29 indexed citations
17.
Ashton, Laura V., Ifigenia Geornaras, J.D. Stopforth, et al.. (2006). Fate of Inoculated Escherichia coli O157:H7, Cultured under Different Conditions, on Fresh and Decontaminated Beef Transitioned from Vacuum to Aerobic Packaging. Journal of Food Protection. 69(6). 1273–1279. 4 indexed citations
18.
Stopforth, J.D., Panagiotis Skandamis, Laura V. Ashton, et al.. (2006). Impact of Inoculum Preparation and Storage Conditions on the Response of Escherichia coli O157:H7 Populations to Undercooking and Simulated Exposure to Gastric Fluid. Applied and Environmental Microbiology. 72(1). 672–679. 8 indexed citations
19.
Stopforth, J.D., Laura V. Ashton, P.N. Skandamis, et al.. (2005). Single and sequential treatment of beef tissue with lactic acid, ammonium hydroxide, sodium metasilicate, and acidic and basic oxidized water to reduce numbers of inoculated Escherichia coli O157:H7 and Salmonella Typhimurium. Food Protection Trends. 25(1). 14–22. 8 indexed citations
20.
Koutsoumanis, Konstantinos, Laura V. Ashton, Ifigenia Geornaras, et al.. (2004). Effect of Single or Sequential Hot Water and Lactic Acid Decontamination Treatments on the Survival and Growth of Listeria monocytogenes and Spoilage Microflora during Aerobic Storage of Fresh Beef at 4, 10, and 25°C. Journal of Food Protection. 67(12). 2703–2711. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026